ARMISTICE CAPITAL, LLC

Q3 2021 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2021
Date filed
11/15/2021
Form type
13F-HR
Num holdings
137
Total value ($000)
$5,903,915
Net value change ($000)
+317,349 (5.7%)
New positions
43
Sold out positions
26
Turnover %
33.9%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AVTX 98,100 NEW
INCY 82,045 101.2%
FIVE 67,412 NEW
PCRX 52,416 NEW
BAX 46,649 NEW
JAZZ 42,188 NEW
LOW 39,846 NEW
POST 34,370 NEW
BBY 34,269 NEW
NFLX 34,179 NEW
Top Reduces (Value $000, Stocks/ETFs)
AVTX -127,857 -100.0%
CPB -59,815 -100.0%
LULU -56,933 -100.0%
AMZN -48,226 -56.1%
TH -46,348 -100.0%
WOO -31,135 -100.0%
CLX -29,479 -58.9%
PFE -29,347 -73.2%
WSM -27,619 -67.3%
BIORA THERAPEUTICS, INC. -27,122 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,857,842 (31.5% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type